Board Meetings for PFIZER
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| PFIZER | Pfizer Limited | 07 May 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend | |
| PFIZER | Pfizer Limited | 24 Jan 2018 | Results | Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017. | |
| PFIZER | Pfizer Limited | 10 Nov 2017 | Results | inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017. | |
| PFIZER | Pfizer Limited | 29 Jul 2017 | Results | inter alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter ended June 30, 2017. | |
| PFIZER | Pfizer Limited | 06 May 2017 | Results/Dividend | inter alia, to consider and take on record the Audited Financial Results of the Company for the quarter January 1, 2017 to March 31, 2017 and for the financial year ended March 31, 2017. At the said meeting, the Board of Directors will also consider recommendation of dividend, if any, for the financial year ended March 31, 2017. Further that the Trading Window for trading in the Equity shares of the Company will be closed from April 27, 2017 to May 8, 2017, both days inclusive. | |
| PFIZER | Pfizer Limited | 30 Jan 2017 | Results | inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2016. | |
| PFIZER | Pfizer Limited | 04 Nov 2016 | Results | Inter alia, to consider and take on record the unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2016. Please be informed that the Trading Window for trading in the Equity shares of the Company will be closed from October 26, 2016 to November 6, 2016, both days inclusive. | |
| PFIZER | Pfizer Limited | 05 Aug 2016 | Results | inter alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter and three months ended June 30, 2016. | |
| PFIZER | Pfizer Limited | 06 May 2016 | Results/Dividend | inter alia, to consider and take on record the Audited Financial Results of the Company for the quarter January 1, 2016 to March 31, 2016 and for the financial year ended March 31, 2016. At the said meeting, the Board of Directors will also consider recommendation of dividend, if any, for the financial year ended March 31, 2016. | |
| PFIZER | Pfizer Limited | 03 Feb 2016 | Results | inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2015. | |
| PFIZER | Pfizer Limited | 09 Nov 2015 | Results | Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the second quarter and six months ended September 30, 2015. | |
| PFIZER | Pfizer Limited | 25 Jul 2015 | Results | inter alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter ended June 30, 2015. | |
| PFIZER | Pfizer Limited | 05 May 2015 | Results/Dividend | inter alia, to consider and take on record the Audited Financial Results of the Company for the quarter January 1, 2015 to March 31, 2015 and for the financial year ended March 31, 2015. Further, the Board of Directors will also consider recommendation of dividend, if any, for the financial year ended March 31, 2015. | |
| PFIZER | Pfizer Limited | 14 Feb 2015 | Results | Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2014. | - |
| PFIZER | Pfizer Limited | 06 Nov 2014 | Results | inter alia, to consider and take on record the Unaudited Financial Results of the Company for the second quarter and six months ended September 30, 2014. Further Trading Window for trading in the Equity shares of the Company will be closed from October 22, 2014 to November 7, 2014, both days inclusive. | - |